Imaging　methods　have　the　overwhelming　advantage　of　being　non-invasive　in　the　diagnosis　of　hepatic　lesions　and,　thanks　to　technical　developments　in　the　field　of　ultrasound　(US),　radiation　exposure　can　also　be　avoided　in　many　clinical　situations.　In　particular,　contrast-enhanced　US　(CEUS)　outperforms　other　radiological　methods　in　regard　to　real-time　images,　repeatability,　and　prompt　reporting　and　demonstrates　relatively　few　contraindications　and　adverse　reactions.　In　this　study,　we　reported　in　detail　a　rare　benign　tumor:　hepatic　sclerosed　hemangioma　(HSH).　We　described　US-based　multimodal　imaging　(B-flow　imaging,　US　elastography,　and　Sonazoid　CEUS)　features　of　this　HSH　case.　Furthermore,　by　summarizing　the　recently　published　literature　on　the　imaging　diagnosis　of　HSH,　we　offered　readers　comprehensive　knowledge　of　conventional　imaging　methods　(CT,　MRI)　and　CEUS　in　the　diagnosis　of　HSH　and　preliminarily　discussed　their　mechanism　of　pathology-based　diagnosis.　Our　multimodal　imaging　approach　may　provide　a　diagnostic　strategy　for　HSH,　thus　avoiding　unnecessary　biopsy　or　resection.